# Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

> **NCT01081626** · PHASE4 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 310 (actual)

## Conditions studied

- Ovulation Induction

## Interventions

- **DRUG:** Recombinant FSH (follitropin alpha)

## Key facts

- **NCT ID:** NCT01081626
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081626, "Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01081626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*